Advanced Medical Optics

From Wikipedia, the free encyclopedia

 This article or section needs sources or references that appear in reliable, third-party publications.
Primary sources and sources affiliated with the subject of the article are generally not sufficient for a Wikipedia article. Please include more appropriate citations from reliable sources, or discuss the issue on the talk page.
This article has been tagged since January 2008.
Advanced Medical Optics
Type Public (NYSE: EYE)
Founded Santa Ana, California (2002)
Headquarters Santa Ana, California
Key people James V. Mazzo Chairman, President and CEO
Industry Ophthalmology
Products Ophthalmic pharmaceuticals
Surgical equipment
Contact care products
Employees 3,800 (2007)
Website http://www.amo-inc.com/

Advanced Medical Optics, Inc., (NYSE: EYE) (known as AMO) is a global medical device leader focused on the discovery and delivery of innovative vision technologies that optimize the quality of life for people of all ages. Products in the ophthalmic surgical line include intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastics, microkeratomes and related products used in cataract and refractive surgery. AMO is based in Santa Ana, California, and employs approximately 4,200 worldwide. The company has operations in 24 countries and markets products in approximately 60 countries.

Contents

[edit] History

AMO was spun off from Allergan in 2002.

[edit] Voluntary recall

AMO volunatrily recalled some of their products in 2006 due to a bacterial contamination in the factory process which would have compromised sterility. Non-sterility of a contact lens solution may have serious health consequences, including eye infection and microbial keratitis. The voluntary and limited recall was caused by an isolated production line problem that affected two of the four production lines in the AMO facility, not because of a formulation issue.

This happened in the midst of a recall scare period caused by Bausch & Lomb's worldwide product recall, after eye care doctors in Singapore traced 90% of their patients' eye infections, some to the serious extent of causing blindness, to B&L products. In fact, no reports of adverse health effects due to the suspected-affected batch of products were made to AMO.

In some countries, there were initial confusion between B&L's product dangers and AMO's voluntary recall.

[edit] Mandatory Recall

AMO announced a recall on Complete MoisturePlus contact lens solution on May 28th, 2007. [1] The solution has been linked to cases of an eye infection (keratitis) caused by an organism of the genus Acanthamoeba. [2]

[edit] Consumer products

[edit] All-in-one Systems for soft contact lenses

  • COMPLETE Blink-N-Clean Lens Drops
  • COMPLETE Moisture PLUS
    • COMPLETE Moisture PLUS 120ml+lens case
    • COMPLETE Moisture PLUS 24ml
    • COMPLETE Moisture PLUS 360ml+lens case
    • COMPLETE Moisture PLUS half Year packages
    • COMPLETE Moisture PLUS Duo Pack
    • COMPLETE Moisture PLUS lens case

[edit] Hydration Solutions

  • Blink Contacts 10ml
  • Blink Contacts 20*0.35ml
  • Blink Eyedrops 10ml
  • Blink Eyedrops 20*0.35ml

[edit] Systems for formstabile, permiable contact lenses

  • Totalcare All-in-One
  • Totalcare Solution
  • Totalcare Cleaner
  • Totalcare Tablets
  • Totalcare Lens case

[edit] Protein Removers

  • Ultrazyme Tablets

[edit] Multipurpose Solutions

  • COMPLETE Moisture PLUS Lubricating and Rewetting Drops

[edit] Peroxide Systems

  • Oxysept 1 Step 1 Month
  • Oxysept 1 Step 3 Months
  • Oxysept 1 Step 6 Months
  • Oxysept 1 Step Tablets
  • Oxysept 1 Step Lens case
  • UltraCare Disinfecting Solution/Neutralizer
  • Ultrazyme Enzymatic Cleaner

[edit] Surgical Products

[edit] External links